The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 01, 2026
Snapshot (as of Sep 01, 2026): Johnson & Johnson (JNJ) pays a $5.28 annual dividend ($1.34 quarterly), yielding 1.96% at $269.32/share. Next ex-dividend date 2026-08-25. 62+ consecutive years of dividend growth (Dividend King). Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.96%
Annual Dividend: $5.28 per share
Payout Ratio: 60.0%
Ex-Dividend Date: 2026-08-25
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 65
Johnson & Johnson is a Dividend King with 62 consecutive years of dividend increases, operating across pharmaceuticals and medical devices through its Innovative Medicine and MedTech segments. The current dividend yield sits at 1.97%, with JNJ paying $5.28 per share annually in quarterly installments. The next ex-dividend date is August 25, 2026, with the most recent quarterly payment of $1.34 per share. A beta of 0.231 marks this as one of the lower-volatility names in healthcare, which suits income investors who prioritize payment reliability over yield size.
Johnson & Johnson pays out 60.0% of earnings as dividends, a payout ratio classified as elevated (60–75%). The company's two operating segments, Innovative Medicine and MedTech, span immunology, oncology, orthopaedics, and surgery, areas with recurring demand that supports the current payout level. Johnson & Johnson dividend safety is further reinforced by 62 unbroken years of increases, though a payout ratio at the upper end of the moderate range leaves less room to absorb earnings pressure without slowing future growth.
Johnson & Johnson dividend history shows a CAGR of 6.1% per year from 2011 to 2025. The per-share payment grew from $2.25 to $5.14 over that period (2026 data is partial and excluded from the growth calculation). The smallest annual increase in the window was 4.5% in 2024, which sets a realistic floor for what income investors can expect in slower years.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +4.9% | $4.45 (2022) | $5.14 (2025) |
| 5-Year | +5.2% | $3.98 (2020) | $5.14 (2025) |
| 10-Year | +5.7% | $2.95 (2015) | $5.14 (2025) |
Johnson & Johnson fits dividend investors who want a Dividend King with an unbroken 62-year increase streak and low price volatility, and who can accept a yield that is low (below 2%). At 1.97%, the current yield is modestly above the 5-year average of 1.75%, which means income buyers are getting a slightly better entry point on yield than the recent norm. The 6.1% annual dividend growth rate over 14 years is the real draw here: the income stream compounds meaningfully over time, even if the starting yield is modest. The trade-off is a 60.0% payout ratio that leaves limited buffer, and a yield that income-focused investors accustomed to higher-yielding sectors will find thin.
JNJ is a Dividend King — 62 consecutive years of dividend increases.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-25 | $1.3400 |
| 2026-05-26 | $1.3400 |
| 2026-02-24 | $1.3000 |
| 2025-11-25 | $1.3000 |
| 2025-08-26 | $1.3000 |
| 2025-05-27 | $1.3000 |
| 2025-02-18 | $1.2400 |
| 2024-11-26 | $1.2400 |
| 2024-08-27 | $1.2400 |
| 2024-05-20 | $1.2400 |
| Year | Total Dividends |
|---|---|
| 2026 | $3.9800 |
| 2025 | $5.1400 |
| 2024 | $4.9100 |
| 2023 | $4.7000 |
| 2022 | $4.4500 |
Project income from JNJ with the JNJ dividend calculator or track your full portfolio with the dividend tracker.